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The Problem of Space Motion Sickness
Space motion sickness is a disorder which produces symptoms similar to those of motion
sickness on Earth. This syndrome has affected approximately 50% of all astronauts and cos-
monauts exposed to microgravity in space, but it differs from what is commonly known as
motion sickness in a number of critical ways. There is currently no ground-based method for
predicting susceptibility to motion sickness in space. Antimotion sickness drugs have had
limited success in preventing or counteracting symptoms in space, and frequently caused
debilitating side effects. For example, the Physician's Desk Reference (1988, p. 2300) cautions
under Information for Patients that one of the drugs used to counteract motion sickness,
"Promethazine may impair the mental and/or physical abilities required for the performance of
potentially hazardous tasks such as driving a vehicle or operating machinery." There are no data
from space on the effects of this medication on crew performance.
Biomedical data from past space missions indicate that some individuals who have had
wide exposure to motion devices and acceleratory forces on Earth or in aircraft, and who have
never previously shown any tendency to develop motion sickness symptoms, were severely
debilitated in the microgravity environment (Bungo et al., 1987). Conversely, some individuals
who had a history of susceptibility to motion sickness were unaffected by symptoms in space.
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Symptom episodes vary from mild discomfort to repeated vomiting which sometimes occurs
suddenly, with little or no warning. The earliest reported episode began within only 7 minutes of
orbit insertion, and malaise has been reported to last from I to 5 days. Finding a solution to this
biomedical problem has become a high priority goal of NASA because of its potential impact on
crew safety, comfort, and operational efficiency during shuttle missions.
Most of the research in this field has been devoted to the study of vestibular physiology,
perceptual phenomena, or pharmacological intervention in man and in animals (Reason & Brand,
1975). In contrast, the primary objective of our own research group has been to develop a
method of training people to control their own motion sickness symptoms (Cowings, 1990;
Blizzard et al., 1975; Cowings et al., 1977; Cowings and Toscano, 1977, 1982; Toscano and
Cowings, 1977; Cowings et al., 1986, 1990). Our method of treatment is Autogenic-Feedback
Training (AFT), a combination of biofeedback and Autogenic Therapy (Schultz & Luthe, 1969),
which involves training physiological self-regulation as an alternative to pharmacological
management. The rationale for using AFT to treat motion sickness was based on the observation
that there were profound autonomic nervous system (ANS) changes associated with this disorder
(Cowings et al., 1986) and, although these responses arc highly idiosyncratic, they are repeatable
over time (Cowings et ai., 1990). By studying physiological and behavioral indicators of human
adaptation to the microgravity environment, we hoped to use these training techniques to
facilitate adaptation.
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Objectives
1. To evaluate the effectiveness of Autogenic-Feedback Training as a countermeasure for
space motion sickness.
2. To compare physiological data and in-flight symptom reports to ground-based motion
sickness data.
3. To predict susceptibility to space motion sickness based on pre-flight data of each
treatment group crew member.
- Ground Studies
Physiological Responses to Motion Sickness Stimuli
The relative importance of ANS responses in understanding and treating motion sickness
has been a matter of some controversy. Money (1970), in his review of motion sickness re-
search, discussed many possible ANS changes during motion sickness, but correctly noted that
there was little consistency in either procedures used or results of the available research.
In a recent paper (Cowings et al., 1986), we examined the data of 127 people, all given
the same motion sickness test in order to describe the general trend of ANS responses in all
subjects. Our own laboratory work suggested that differences in initial susceptibility may
account for at least one major source of variability in ANS responding reported by others. We,
therefore, also investigated whether high-, moderate-, and low-susceptible individuals differed in
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their ANS responding to motion stimulation. And last, we examined autonomic responses as
predictors of motion sickness susceptibility. We used the ANS variables of heart rate, respiration
rate, finger pulse volume, and skin resistance because they were easily measured, represent
different aspects of the ANS, and have been used in previous studies on motion sickness.
The results clearly showed sympathetic activation of all four ANS responses during
motion sickness stimulation. Physiological response levels changed rapidly and dramatically at
the onset of stimulation and when the test concluded. We also found differences in ANS
responding among motion sickness susceptibility groups, with highly susceptible subjects
producing, in general, larger magnitude changes than the moderate or low susceptibles.
In another study, comparisons were made of two separate motion sickness tests on each
of 58 subjects (Cowings et al., 1990). Again, the same four physiological responses (heart rate,
finger pulse volume, respiration rate, and skin resistance) were measured during both motion
tests. The goal of this study was to examine individual differences in physiological responding
(i.e., response patterns) to motion stimuli, and determine how these data were related to self-
reports of motion sickness malaise experienced. The phenomenon of individual ANS stereotype,
that propensity of individuals to respond maximally in the same ANS variable to a variety of
different stimuli, is well known in the psychophysiological literature (Cleary, 1974; Engle, 1960;
Lacey, 1956; Lacey et al., 1953). In the presence of any stimulus (for example, a loud noise), all
subjects might show a rise in heart rate, but some individuals will make a much larger response
than others. And for any given individual, the heart rate response may be of greater magnitude
than his or her skin resistance level or other measured responses.
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The results revealed 11 separate patterns of physiological responding in which all or
some combination of the four physiological measures clearly reflected motion sickness malaise
levels of each of the 58 subjects. Individual response patterns produced on the first tests were
not significantly different than those of the second test. Analyses showed that of the 58 subjects,
27 showed the same response patterns on both tests for all four physiological measures, 14 were
stable for three variables, 6 were stable for two, and 11 were stable responders for at least one
variable.
General Procedures of Training
Because certain ANS responses were correlated with, and indeed predictors of motion
sickness distress, it was hypothesized that training subjects to control these responses might
prevent or reduce symptoms. The observed individual differences in responding suggested that,
to be effective, such training would have to be directed at the different responses for different
people. In other words, training would have to be "tailored" for each individual. The training
procedure we used, AFT, was based on the principals of operant conditioning.
Operant conditioning describes a trial and error process in which the response learned and
performed must be followed by either a reward or a punishment (i.e., contingent reinforcemen0.
When a novice is learning better voluntary control over where the basketball goes in shooting
foul shots, seeing the ball go through the hoop (success) serves as a reward, and seeing it miss
(failure) serves as a punishment. If the novice were blindfolded so that he did not have any
knowledge of the results of his shots, he would not learn. It was Miller's contention (Miller,
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1969)thatvisceral and CNS events may be modified by contingent reinforcement in the same
way overt behaviors or skeletal responses may be conditioned. Hence, the "same rules" apply for
describing the process by which athletic skills are acquired, as in the situation where an individ-
ual learns voluntary control of his own heart rate or the vasomotor activity of his hands. To learn
control of a physiological response, the subject must be given a means of perceiving that
response. The "blindfold" is removed by showing a subject (for example) an amplified display
of his own heart rate on a digital panel meter. This process is called biofeedback.
AFT is actually a combined application of several physiological and perceptual training
techniques, principal among these are Autogenic Therapy (Schultz and Luthe, 1969) and biofeed-
back. This combined therapies approach produces a methodology which is appreciably more
effective than either of these two techniques when used alone (Blizzard et al., 1975; Cowings and
Toscano, 1977). Autogenic exercises provide the subject with a specific set of instructions and
method of concentration which are likely to produce the desired response. For example, self-
suggestions of warmth in the hands and feet are associated with measurable increases in
peripheral vasodilatation (Harano et al., 1973). Consequently, the time normally spent by the
subject using a trial and error strategy is shortened and the initial probability of making a correct
response is substantially increased. Biofeedback complements Autogenic Therapy by providing
immediate sensory information to the subject about the magnitude and direction of a response.
Operant conditioning procedures allow for more precise control of a response, as the "reward"
(or feedback) can be presented only as the subject makes gradually larger response changes in the
desired direction. As a result, the ultimate effectiveness of training is significantly increased.
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During a typical training session, subjects arc instructed to control a pattern of
physiological responses and arc given many different feedback displays (visual and auditory),
simultaneously. Multiparameter feedback re.quires additional training in attending to a complex
set of feedback signals. Verbal instructions by the experimenter arc often required to direct the
subject's attention to specific feedback signals and to advise him of alternative strategies when
an inappropriate response has occurred. Included in these alternative strategies are elements of
systematic desensitization and progressive relaxation of muscle tension monitored at several
sites.
The protocol for all of our ground-based studies was essentially the same. First, a rotat-
ing chair test was used to induce the initial symptoms of motion sickness. In this way, we could
document the pattern of his physiological responses to motion stimulation. The rotating chair
tests were conducted by initiating rotation at 6 rpm (0.628 tad/s) and incrementing by 2 rpm
(0.209 rad/s) every 5 minutes, with a maximum velocity of 30 rpm (3.142 rad/s). During each
5-minute period of rotation, subjects were instructed to make head movements (front, back, left,
and right), in random order, at 2-second intervals. It is these head movements combined with
rotation which induce motion sickness symptoms. Every 5 minutes during the test, subjects were
asked about the symptoms that they were experiencing using a standardized diagnostic scoring
procedure so that we can accurately assess the relationship between his perceived distress and his
physiological responses at any given time (Cowings et al., 1986; Graybiel et al., 1968).
Initial exposure to the rotating chair was followed by two (or four) resting baseline
sessions and a second rotating chair test. This procedure enabled us to clearly identify which
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ANS responses changed from the subject's own resting baseline as a function of motion sickness
stimulation. During subsequent AFT sessions, emphasis was placed on training control of those
ANS variables that were most responsive in the individual's motion sickness tests. APT was
administered in three sets of four 30-minute sessions (maximum 6 hours) under non-rotating
conditions. Each AFT set was followed by a rotating chair test in which the subject attempted to
apply APT to control symptoms. The primary criterion for evaluating treatment success was
increased tolerance (i.e., ride for longer durations at higher speeds) to this motion sickness
stimulus.
Results of Ground-Based Research
In preparation for tests of AFT in space, we have conducted investigations on over 200
people. Each study was designed to test the effectiveness of AFT as a countermeasure for
motion sickness and the feasibility of using this method to treat space motion sickness in
aerospace crews. Another important objective was to determine if the reduction in symptoms
observed could be attributed to some experimental factor other than AFT.
In one study, differences in motion sickness tolerance were Compared in subjects given
AFT, an alternative cognitive task, or no treatment (Toscano and Cowings, 1982). Two hours of
AFT were administered to treatment group subjects before the third, fourth, and fifth motion
sickness test (6 hours total). Figure 1 shows the performance of all three groups in the motion
sickness tests. Results showed that subjects who received APT had significantly greater motion
sickness tolerance than sub_ects performing an alternative cognitive task (p < 0.025) or those
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performingno task(p < 0.025). Although the cognitive task group had slightly greater tolerance
than the no-task control group, it was not significant.
Another experiment was designed to determine if an individual's initial susceptibility to
motion sickness was related to his ability to learn control of symptoms (Cowings and Toscano,
1982). Following an initial exposure to a rotating chair test, subjects were assigned to groups
based on their motion sickness tolerance. Two AFT treatment groups (highly and moderately
susceptible to motion sickness) were compared to two control groups who were matched to the
AFT groups for initial susceptibility but were given no treatment. Figure 2 shows the perform-
ance of these groups across six motion sickness tests. Results showed that both AFT treatment
groups significantly improved their motion sickness tolerance while neither Control group
improved significantly. During the last two tests, after 6 hours of AFT, the high and moderate
susceptible treatment groups were no longer significantly different in their motion sickness
tolerance, while the high and moderate control groups remained significantly different across all
teStS.
The results of other studies showed: (1) no significant differences between men and
women in their ability to apply AFT for symptom control; (2) the ability to control symptoms
could be retained for as long as 3 years after training; and (3) the primary component of the
treatment effect in each of these studies could be attributed to learned control of physiological
responses (Cowings, 1990). The most important studies, however, revealing the likelihood of
AFT being a successful treatment in space, were related to the transfer of training effects to a
variety of different environments.
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Transfer of Training Effects to Different Motion Environments
Experiments in the literature (Reason and Brand, 1975) and clinical experience show that
habituation to a specific nauseogenic situation does not transfer to new situations. Repeated
exposure apparently effects primarily the sensory side (or "input" side) of the response system.
AFT is aimed at controlling the "output" side, i.e., the various symptoms of motion sickness. To
the extent that such control can be learned, we would expect it to be much more likely to transfer
to different situations that induce nausea.
An extensive examination of transfer of training was made in another study which
involved several different types of motion sickness stimuli. Twenty-four men and women were
assigned to two equal groups and matched for sex and initial susceptibility to motion sickness in
a rotating chair. The two groups of subjects, an AFT treatment group and a no-treatment control
group, were given three types of motion sickness inducing tests at the start of the study: (a)
rotating chair test, (b) the combination of optokinetic stimulation with rotation in a chair, and (c)
a vertical acceleration test. All subjects received four additional exposures to the rotating chair.
Treatment subjects were given 6 hours of AFT over 5 days before tests three, four, and five. The
controls received no training. Both groups of subjects were given their second exposure to the
battery of different types of motion sickness tests at the end of the experiment. Figure 3 shows
the performance of both groups on the transfer tests, vertical acceleration, and optokinetic
stimulation. Because these tests had different maximum durations, scores for motion sickness
tolerance were based on percentages of the total test completed.
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Results showed that subjects given AFF significantly improved their tolerance to the
different types of motion sickness tests, whereas the control subjects (habituation only) did not.
Furthermore, the Air Force had adopted a similar form of AFT to treat crew members for whom
all other methods had proved unsuccessful in combatting persistent air sickness in high perform-
ance military planes (Levy et al., 1981; Jones et al., 1985). They have found that such training
transfers from the rotating chair on the ground to the variety of maneuvers in military flight well
enough to return air crew that otherwise would have been permanently grounded, to active flying
duty. These results on transfer of control over response symptoms to different types of stimuli
diciting nausea led us to be hopeful of transfer to the stimuli cliciting symptoms in space. What
little preliminary data we have from space flight confirms this hypothesis.
Four crew members (two treatment and two controls) participated in the AFT experiment
during a 1985 shuttle mission (Cowings et ai., 1986). The treatment subjects were given 6 hours
of AFT before the mission (distributed from launch -1 year to launch -3 months), and control
subjects received no training. During the mission, one treatment subject was symptom free and
the other experienced one symptom episode on the first mission day which did not reach vomit-
ing. The two controls, who had taken anti-motion sickness medication, experienced multiple
vomiting episodes on the In'st day. The physiological data collected in-flight were consistent
with reports of malaise, with treatment subjects showing less physiological distress than either of
the controls.
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Flight Experiment Design
Preflight Training
$7 _
One year prior to the flight the SL-J crew members began their participation in AFTE.
One Mission Specialist will receive 6 hours of AFT for the control of motion sickness, and a
second Mission Specialist will serve as a control (i.e., will receive no training). In addition, the
alternate crew members and the Japanese Payload Specialist will be provided with this training.
1. Baseline data collection. Physiological data are obtained from all subjects during two types of
motion sickness_tests, a rotating chair and a Vertical accelerator. Additionally, data are recorded
during two resting baseline (30 minute) sessions, two 12-hour ambulatory sessions during a
mission simulation, during zero-g maneuvers in the KC-135 aircraft, and during a 90-minute
reclining baseline in the launch position in a shuttle mock-up.
2. Formal AFT sessions. The design of training is much the same as the ground-based studies
described above. Twelve 30-minute sessions are administered (at the PI's laboratory) over a
15-day period, with each block (4 consecutive days) of training followed by a motion sickness
rotating chair test. The principal criterion for evaluating the success of the AFT treatment is the
increased time that crew members tolerate these tests as training progresses.
If the launch should slip more than 4 months, crew members are offered an additional
block of training sessions (4 consecutive days).
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3. Follow-up AFT sessions. During the launch-6 to I month period, AFT training continues in
the form of follow-up sessions at any location (e.g., JSC or MSFC). Flight hardware (see Figure
4) will be used to monitor and feedback physiological measures during training for a total of
eight (30 minute) sessions.
4. L-10 day session. This 2-hour session is the last time investigators contact crew members
prior to the mission. It allows us to document the amount of physiological control retained by
the treatment subjects and any differnces (from previous sessions) in baseline levels of these
subjects or the control subjects.
In-Flight Procedures and Flil_ht Hardware
1. Continuous day-time monitoring. During the mission, the physiological responses of both the
treatment and control subjects will be monitored and recorded for the first three mission days
(waking hours only). The Autogenic-Feedback System-2 (AFS-2) is a portable belt-worn
physiological monitoring system (see Figure 4). Developed by NASA in support of space flight
experiments, this system can continuously record up to eight physiological responses. This
system includes a garment, transducers, biomedical amplifiers, a digital wrist-worn feedback
display, and a cassette tape recorder. The entire instrument is powered by a self-contained
battery pack. The AFS-2 will record/display: electrocardiogram/heart rate, respiration
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waveform/respiration rate, skin conductance level, finger temperature, finger pulse volume, and
triaxial accelerations of the head.
2. Timelined and symptom-contingent diagnostic. An eight-item symptom log book will be
used by the crew member to note the type and severity of symptoms.
3. Timelined and symptom-contingent AFT sessions. The treatment subject (only) is required to
p
perform daily 15-minute AFT sessions during which control of specific physiological responses
are practiced with the aid of the wrist-worn display unit. If that crew member were to experience
symptoms in space, he/she is required to apply the AFT methods learned. Symptom-contingent
AFT can be performed at the same time that a crew member is conducting other payload ac-
tivities. It is anticipated that no more than 30 minutes would be required to counteract
symptoms.
Post-Flight Procedures
On the day of landing, AFT investigators are granted a brief (10 minute) interview with
the crew members on their experiences with the AFT experiment. Flight hardware, data tapes,
and diagnostic log books are returned to the PI's laboratory within 24 hours of touch-down.
These data are processed and used within 2 weeks post-flight during a 2-hour private debrief
with each of the crew members where the final evaluation of AFT effectiveness during the
Spacelab-J mission is determined.
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Summary
Finding an effective treatment of the motion sickness-like symptoms that occur in space
has become a high priority for NASA. This experiment utilizes a behavioral medicine approach
to solving this problem. This method, Autogenic-Feedback Training (AFT), involves training
subjects to voluntarily control several of their own physiological responses to environmental
strcssors. AFT has been used to reliably increase tolerance to motion sickness during ground-
based tests in over 200 men and women under a variety of motion sickness conditions. Such
transfer would be expected because the effects of AFT are on the f'mal common response mecha-
nism rather than on initiating stimuli. Thus we might expect it to transfer to space sickness, and
our preliminary data suggest that it may. Validation of the effectiveness of AFT as a treatment
for space motion sickness will require obtaining data on a total of 16 individuals in space, 8
treatment and 8 control subjects. With the completion of Spacelab-J, this procedure will have
been tested on 6 people.
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